Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study

<strong>Background</strong> Antimicrobial resistance is highly prevalent in low-income and middle-income countries. International travel contributes substantially to the global spread of intestinal multidrug-resistant Gram-negative bacteria. Hundreds of millions of annual visitors to low...

Full description

Bibliographic Details
Main Authors: Kantele, A, Kuenzli, E, Dunn, SJ, Dance, DAB, Newton, PN, Davong, V, Mero, S, Pakkanen, SH, Neumayr, A, Hatz, C, Snaith, A, Kallonen, T, Corander, J, McNally, A
Format: Journal article
Language:English
Published: Elsevier 2021
_version_ 1797093202839207936
author Kantele, A
Kuenzli, E
Dunn, SJ
Dance, DAB
Newton, PN
Davong, V
Mero, S
Pakkanen, SH
Neumayr, A
Hatz, C
Snaith, A
Kallonen, T
Corander, J
McNally, A
author_facet Kantele, A
Kuenzli, E
Dunn, SJ
Dance, DAB
Newton, PN
Davong, V
Mero, S
Pakkanen, SH
Neumayr, A
Hatz, C
Snaith, A
Kallonen, T
Corander, J
McNally, A
author_sort Kantele, A
collection OXFORD
description <strong>Background</strong> Antimicrobial resistance is highly prevalent in low-income and middle-income countries. International travel contributes substantially to the global spread of intestinal multidrug-resistant Gram-negative bacteria. Hundreds of millions of annual visitors to low-income and middle-income countries are all exposed to intestinal multidrug-resistant Gram-negative bacteria resulting in 30–70% of them being colonised at their return. The colonisation process in high-exposure environments is poorly documented because data have only been derived from before travel and after travel sampling. We characterised colonisation dynamics by exploring daily stool samples while visiting a low-income and middle-income countries. <br> <strong>Methods</strong> In this prospective, daily, real-time sampling study 20 European visitors to Laos volunteered to provide daily stool samples and completed daily questionnaires for 22 days. Samples were initially assessed at Mahosot Hospital, Vientiane, Laos, for acquisition of extended-spectrum β-lactamase-producing (ESBL) Gram-negative bacteria followed by whole-genome sequencing of isolates at MicrobesNG, University of Birmingham, Birmingham, UK. The primary outcome of the study was to obtain data on the dynamics of intestinal multidrug-resistant bacteria acquisition. <br> <strong>Findings</strong> Between Sept 18 and Sept 20, 2015, 23 volunteers were recruited, of whom 20 (87%) European volunteers were included in the final study population. Although colonisation rates were 70% at the end of the study, daily sampling revealed that all participants had acquired ESBL-producing Gram-negative bacteria at some point during the study period; the colonisation status varied day by day. Whole-genome sequencing analysis ascribed the transient pattern of colonisation to sequential acquisition of new strains, resulting in a loss of detectable colonisation by the initial multidrug-resistant Gram-negative strains. 19 (95%) participants acquired two to seven strains. Of the 83 unique strains identified (53 Escherichia coli, 10 Klebsiella spp, and 20 other ESBL-producing Gram-negative bacteria), some were shared by as many as four (20%) participants. <br> <strong>Interpretation</strong> To our knowledge, this is the first study to characterise in real-time the dynamics of acquiring multidrug-resistant Gram-negative bacterial colonisation during travel. Our data show multiple transient colonisation events indicative of constant microbial competition and suggest that travellers are exposed to a greater burden of multidrug-resistant bacteria than previously thought. The data emphasise the need for preventing travellers' diarrhoea and limiting antibiotic use, addressing the two major factors predisposing colonisation. <br> <strong>Funding</strong> The Finnish Governmental Subsidy for Health Science Research, The Scandinavian Society for Antimicrobial Chemotherapy, the Sigrid Jusélius Foundation, Biotechnology and Biological Sciences Research Council; Wellcome Trust, Medical Research Council; The Royal Society; Joint Programming Initiative on Antimicrobial Resistance, and European Research Council.
first_indexed 2024-03-07T03:56:54Z
format Journal article
id oxford-uuid:c32ef1e4-49d0-43e6-aeb6-c6fc0211d20d
institution University of Oxford
language English
last_indexed 2024-03-07T03:56:54Z
publishDate 2021
publisher Elsevier
record_format dspace
spelling oxford-uuid:c32ef1e4-49d0-43e6-aeb6-c6fc0211d20d2022-03-27T06:14:36ZDynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c32ef1e4-49d0-43e6-aeb6-c6fc0211d20dEnglishSymplectic ElementsElsevier2021Kantele, AKuenzli, EDunn, SJDance, DABNewton, PNDavong, VMero, SPakkanen, SHNeumayr, AHatz, CSnaith, AKallonen, TCorander, JMcNally, A<strong>Background</strong> Antimicrobial resistance is highly prevalent in low-income and middle-income countries. International travel contributes substantially to the global spread of intestinal multidrug-resistant Gram-negative bacteria. Hundreds of millions of annual visitors to low-income and middle-income countries are all exposed to intestinal multidrug-resistant Gram-negative bacteria resulting in 30–70% of them being colonised at their return. The colonisation process in high-exposure environments is poorly documented because data have only been derived from before travel and after travel sampling. We characterised colonisation dynamics by exploring daily stool samples while visiting a low-income and middle-income countries. <br> <strong>Methods</strong> In this prospective, daily, real-time sampling study 20 European visitors to Laos volunteered to provide daily stool samples and completed daily questionnaires for 22 days. Samples were initially assessed at Mahosot Hospital, Vientiane, Laos, for acquisition of extended-spectrum β-lactamase-producing (ESBL) Gram-negative bacteria followed by whole-genome sequencing of isolates at MicrobesNG, University of Birmingham, Birmingham, UK. The primary outcome of the study was to obtain data on the dynamics of intestinal multidrug-resistant bacteria acquisition. <br> <strong>Findings</strong> Between Sept 18 and Sept 20, 2015, 23 volunteers were recruited, of whom 20 (87%) European volunteers were included in the final study population. Although colonisation rates were 70% at the end of the study, daily sampling revealed that all participants had acquired ESBL-producing Gram-negative bacteria at some point during the study period; the colonisation status varied day by day. Whole-genome sequencing analysis ascribed the transient pattern of colonisation to sequential acquisition of new strains, resulting in a loss of detectable colonisation by the initial multidrug-resistant Gram-negative strains. 19 (95%) participants acquired two to seven strains. Of the 83 unique strains identified (53 Escherichia coli, 10 Klebsiella spp, and 20 other ESBL-producing Gram-negative bacteria), some were shared by as many as four (20%) participants. <br> <strong>Interpretation</strong> To our knowledge, this is the first study to characterise in real-time the dynamics of acquiring multidrug-resistant Gram-negative bacterial colonisation during travel. Our data show multiple transient colonisation events indicative of constant microbial competition and suggest that travellers are exposed to a greater burden of multidrug-resistant bacteria than previously thought. The data emphasise the need for preventing travellers' diarrhoea and limiting antibiotic use, addressing the two major factors predisposing colonisation. <br> <strong>Funding</strong> The Finnish Governmental Subsidy for Health Science Research, The Scandinavian Society for Antimicrobial Chemotherapy, the Sigrid Jusélius Foundation, Biotechnology and Biological Sciences Research Council; Wellcome Trust, Medical Research Council; The Royal Society; Joint Programming Initiative on Antimicrobial Resistance, and European Research Council.
spellingShingle Kantele, A
Kuenzli, E
Dunn, SJ
Dance, DAB
Newton, PN
Davong, V
Mero, S
Pakkanen, SH
Neumayr, A
Hatz, C
Snaith, A
Kallonen, T
Corander, J
McNally, A
Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study
title Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study
title_full Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study
title_fullStr Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study
title_full_unstemmed Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study
title_short Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study
title_sort dynamics of intestinal multidrug resistant bacteria colonisation contracted by visitors to a high endemic setting a prospective daily real time sampling study
work_keys_str_mv AT kantelea dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT kuenzlie dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT dunnsj dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT dancedab dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT newtonpn dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT davongv dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT meros dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT pakkanensh dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT neumayra dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT hatzc dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT snaitha dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT kallonent dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT coranderj dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy
AT mcnallya dynamicsofintestinalmultidrugresistantbacteriacolonisationcontractedbyvisitorstoahighendemicsettingaprospectivedailyrealtimesamplingstudy